08 August 2020 : Clinical Research
Protective Effect of Probiotics against Esophagogastric Variceal Rebleeding in Patients with Liver Cirrhosis after Endoscopic Therapy
Qun Zhang1CDE, Fangyuan Gao1CD, Xue Yang1D, Ying Hu1D, Yao Liu1CD, Yixin Hou1D, Yuxin Li1D, Bingbing Zhu2B, Shuaishuai Niu1BF, Yunyi Huang3B, Xianbo Wang1ADG*DOI: 10.12659/MSM.924040
Med Sci Monit 2020; 26:e924040
Supplementary Table 3 Subgroup analysis of patients with other etiologies.
| Probiotics cohort all (rebleeding) | Non-probiotics cohort all (rebleeding) | P-value* | |
|---|---|---|---|
| Other HBV irrelevant (n=109) | 41 (17) | 68 (40) | 0.037 |
| Other HBV correlation (n=5) | 2 (1) | 3 (3) | 0.360 |
| HBV – hepatitis B virus. * Subgroup analysis of esophagogastric variceal rebleeding in patients from the probiotics and non-probiotics cohorts using Cox regression. | |||